华兰生物: 关于董事会换届选举的公告

Core Viewpoint - The company is undergoing a board re-election process, transitioning from the eighth to the ninth board, with specific candidates nominated for both independent and non-independent director positions [1][2]. Board Election Summary - The ninth board will consist of 9 directors, including 6 non-independent directors (one being a representative of employees) and 3 independent directors [1]. - Candidates for non-independent directors include An Kang, Fan Bei, An Wenqi, An Wenjue, and Pan Ruowen, while candidates for independent directors are Su Zhiguo, Wang Yunlong, and Liu Wanli [2]. - The election will be conducted at the shareholders' meeting using a cumulative voting system, requiring approval from the shareholders [2][3]. Candidate Qualifications - The nomination committee has confirmed that all candidates meet the qualifications required by relevant laws and the company's articles of association [2]. - An Kang, the actual controller of the company, holds 327,787,406 shares and has not faced any penalties from regulatory bodies [4]. - Fan Bei, An Wenqi, An Wenjue, and Pan Ruowen have extensive experience within the company and have not faced any regulatory penalties [5][6]. Independent Directors - Su Zhiguo, Wang Yunlong, and Liu Wanli are nominated as independent directors, with Liu Wanli being a qualified accountant [7][8][9]. - All independent director candidates have no conflicts of interest with the company and have not faced any penalties from regulatory authorities [7][8][9].